Goldman Sachs Group »

Pieris Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Pieris Pharmaceuticals (PIRS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Pieris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pieris Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pieris Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $4.1k 23k 0.18
2023-09-30 $6.7k 23k 0.30
2023-06-30 $4.1k 25k 0.17
2023-03-31 $48k 49k 0.98
2022-12-31 $52k 50k 1.04
2022-06-30 $149k 80k 1.87
2022-03-31 $591k 195k 3.03
2021-12-31 $1.8M 483k 3.78
2021-09-30 $2.6M 499k 5.17
2021-03-31 $609k 237k 2.57
2020-12-31 $780k 311k 2.50
2020-09-30 $696k 337k 2.07
2020-06-30 $1.1M 356k 3.10
2019-12-31 $1.1M 302k 3.61
2019-09-30 $1.1M 336k 3.40
2019-06-30 $2.2M 474k 4.73
2019-03-31 $1.8M 542k 3.35
2018-12-31 $1.7M 625k 2.66
2018-09-30 $3.6M 641k 5.60
2018-06-30 $3.5M 699k 5.07
2018-03-31 $4.6M 667k 6.83
2017-12-31 $2.0M 262k 7.53
2017-09-30 $573k 100k 5.74
2017-06-30 $60k 12k 5.02